Literature DB >> 25776820

Peripheral neuropathies: new recommendations for neuropathic pain pharmacotherapy.

Claudia Sommer1.   

Abstract

A recent review and meta-analysis on pharmacotherapy for neuropathic pain provides a precise update on treatment efficacy and adverse effects. The authors offer revised evidence-based recommendations for first-line therapies and subsequent options, but we still a need to improve individual treatment decisions, including nonpharmacological therapies, in affected patients.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25776820     DOI： 10.1038/nrneurol.2015.36

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


  9 in total

1.  Trigeminal neuralgia: its treatment with a new anticonvulsant drug (G-32883).

Authors:  S BLOM
Journal:  Lancet       Date:  1962-04-21       Impact factor: 79.321

2.  [Preliminary note on the action of imipramine in painful states].

Authors:  F PAOLI; G DARCOURT; P COSSA
Journal:  Rev Neurol (Paris)       Date:  1960-05       Impact factor: 2.607

Review 3.  Efficacy and safety of opioid agonists in the treatment of neuropathic pain of nonmalignant origin: systematic review and meta-analysis of randomized controlled trials.

Authors:  Elon Eisenberg; Ewan D McNicol; Daniel B Carr
Journal:  JAMA       Date:  2005-06-22       Impact factor: 56.272

4.  Towards a mechanism-based classification of pain?

Authors:  Clifford J Woolf; Gary J Bennett; Michael Doherty; Ronald Dubner; Bruce Kidd; Martin Koltzenburg; Richard Lipton; John D Loeser; Richard Payne; Eric Torebjork
Journal:  Pain       Date:  1998-09       Impact factor: 6.961

Review 5.  Interventional management of neuropathic pain: NeuPSIG recommendations.

Authors:  Robert H Dworkin; Alec B O'Connor; Joel Kent; Sean C Mackey; Srinivasa N Raja; Brett R Stacey; Robert M Levy; Miroslav Backonja; Ralf Baron; Henning Harke; John D Loeser; Rolf-Detlef Treede; Dennis C Turk; Christopher D Wells
Journal:  Pain       Date:  2013-06-06       Impact factor: 6.961

6.  The nature of opioid responsiveness and its implications for neuropathic pain: new hypotheses derived from studies of opioid infusions.

Authors:  Russell K Portenoy; Kathleen M Foley; Charles E Inturrisi
Journal:  Pain       Date:  1990-12       Impact factor: 6.961

7.  A systematic review of antidepressants in neuropathic pain.

Authors:  H J McQuay; M Tramèr; B A Nye; D Carroll; P J Wiffen; R A Moore
Journal:  Pain       Date:  1996-12       Impact factor: 6.961

Review 8.  Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis.

Authors:  Nanna B Finnerup; Nadine Attal; Simon Haroutounian; Ewan McNicol; Ralf Baron; Robert H Dworkin; Ian Gilron; Maija Haanpää; Per Hansson; Troels S Jensen; Peter R Kamerman; Karen Lund; Andrew Moore; Srinivasa N Raja; Andrew S C Rice; Michael Rowbotham; Emily Sena; Philip Siddall; Blair H Smith; Mark Wallace
Journal:  Lancet Neurol       Date:  2015-01-07       Impact factor: 44.182

9.  Management of chronic neuropathic pain: a protocol for a multiple treatment comparison meta-analysis of randomised controlled trials.

Authors:  Sohail M Mulla; D Norman Buckley; Dwight E Moulin; Rachel Couban; Zain Izhar; Arnav Agarwal; Akbar Panju; Li Wang; Sun Makosso Kallyth; Alparslan Turan; Victor M Montori; Daniel I Sessler; Lehana Thabane; Gordon H Guyatt; Jason W Busse
Journal:  BMJ Open       Date:  2014-11-20       Impact factor: 2.692
  9 in total
  4 in total

1.  Chloride Homeostasis Critically Regulates Synaptic NMDA Receptor Activity in Neuropathic Pain.

Authors:  Lingyong Li; Shao-Rui Chen; Hong Chen; Lei Wen; Walter N Hittelman; Jing-Dun Xie; Hui-Lin Pan
Journal:  Cell Rep       Date:  2016-05-05       Impact factor: 9.423

2.  Adding Genetic Testing to Evidence-Based Guidelines to Determine the Safest and Most Effective Chronic Pain Treatment for Injured Workers.

Authors:  Brian Meshkin; Katrina Lewis; Svetlana Kantorovich; Natasha Anand; Lisa Davila
Journal:  Int J Biomed Sci       Date:  2015-12

3.  Identification of Slc6a19os and SOX11 as Two Novel Essential Genes in Neuropathic Pain Using Integrated Bioinformatic Analysis and Experimental Verification.

Authors:  Peng Chen; Chen Wang; Dongsheng Lin; Bing Li; Shuai Ye; Jinglian Qu; Wenjing Wang
Journal:  Front Neurosci       Date:  2021-01-28       Impact factor: 4.677

4.  Proteomic Analysis of Emodin Treatment in Neuropathic Pain Reveals Dysfunction of the Calcium Signaling Pathway.

Authors:  Peng Chen; Dongsheng Lin; Chen Wang; Cuiwen Song; Wenjing Wang; Jinglian Qu; Zhibing Wu
Journal:  J Pain Res       Date:  2021-03-05       Impact factor: 3.133
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.